OXYNORM Side Effects

6430292-9 | Delirium
on Oct 30, 2009 Female patient from NORWAY , weighting 77.60 lb, was treated with Oxynorm (View Usage). Patient experienced the following unwanted or unexpected effects: delirium. Oxynorm dosage: . During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), VESICARE /01735901/ (View Vesicare /01735901/ Review and Vesicare /01735901/ Label ), TRAMAGETIC (View Tramagetic Review and Tramagetic Label ), EFEXOR /01233801/ (View Efexor /01233801/ Review and Efexor /01233801/ Label ), KEPPRA (View Keppra Review and Keppra Label ), STESOLID (5 Mg, Prn) (View Stesolid Review and Stesolid Label ), CALCIGRAN /00944201/ (View Calcigran /00944201/ Review and Calcigran /00944201/ Label ), ALBYL E (75 Mcg, Unk) (View Albyl-e Review and Albyl-e Label ).

6409956-9 | Blister, Erythema, Panic Attack
Patient was taking Oxynorm (View Usage). Patient had the following side effects: blister, erythema, panic attack on Oct 09, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 41 years of age, was diagnosed with pain (What is pain?) and. Oxynorm dosage: 10 Mg, Daily. During the same period patient was treated with TARGINACT 10MG/5MG (10 Mg, Bid) (View Targinact 10mg/5mg Review and Targinact 10mg/5mg Label ), TRAMADOL HCL (Unk) (View Tramadol Hcl Review and Tramadol Hcl Label ), DIAZEPAM (2 Mg, Tid Prn) (View Diazepam Review and Diazepam Label ), FOLIC ACID (5 Mg, Daily) (View Folic Acid Review and Folic Acid Label ), HYDROXOCOBALAMIN (1 Mg/ml, Every 3 Months) (View Hydroxocobalamin Review and Hydroxocobalamin Label ), WARFARIN SODIUM (1 Mg, Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6382284-6 | Aggression, Agitation, Anxiety, Confusional State, Delirium, Hypercalcaemia, Malignant Neoplasm Progression, Metastases To Liver, Metastases To Pleura
Adverse event was reported on Sep 22, 2009 by a Male patient taking Oxynorm (View Usage) (Dosage: Unk) was diagnosed with metastatic renal cell carcinoma and. Location: UNITED KINGDOM , weighting 125.0 lb, After Oxynorm was administered, patient had the following side effects: aggression, agitation, anxiety (What is anxiety?), confusional state, delirium, hypercalcaemia, malignant neoplasm progression, metastases to liver, metastases to pleura. During the same period patient was treated with RAD001 (10 Mg, Daily) (View Rad001 Review and Rad001 Label ), PALLADONE /00080902/ (Unk) (View Palladone /00080902/ Review and Palladone /00080902/ Label ), AMITRIPTYLINE (Unk) (View Amitriptyline Review and Amitriptyline Label ), METHADONE HYDROCHLORIDE (Unk) (View Methadone Hydrochloride Review and Methadone Hydrochloride Label ), ETHANOL (View Ethanol Review and Ethanol Label ). Patient was hospitalized.

6123862-9 | Encephalopathy, Somnolence
on Mar 12, 2009 Female patient from FRANCE , 79 years of age, was diagnosed with abdominal pain upper and was treated with Oxynorm (View Usage). Patient experienced the following unwanted or unexpected effects: encephalopathy, somnolence. Oxynorm dosage: .5 Mg, Q1h. During the same period patient was treated with TEMESTA /00273201/ (4 Mg, Daily) (View Temesta /00273201/ Review and Temesta /00273201/ Label ), MEPRONIZINE /00789201/ (1 Df, Daily) (View Mepronizine /00789201/ Review and Mepronizine /00789201/ Label ), EUPANTOL /01263201/ (40 Mg, Unk) (View Eupantol /01263201/ Review and Eupantol /01263201/ Label ), LIPANTHYL (1 Df, Daily) (View Lipanthyl Review and Lipanthyl Label ), ACUPAN (View Acupan Review and Acupan Label ), DIANTALVIC (Unk, Unk) (View Diantalvic Review and Diantalvic Label ). Patient was hospitalized.


6105009-8 | Disease Progression
on Feb 26, 2009 Female patient from IRELAND , 78 years of age, was diagnosed with pain (What is pain?) and was treated with Oxynorm (View Usage). Patient had the following side effects: disease progression. Oxynorm dosage: 5 Mg, Unk. During the same period patient was treated with OXYCONTIN (10 Mg, Bid) (View Oxycontin Review and Oxycontin Label ), MOTILIUM /00498201/ (10 Mg, Tid Prn) (View Motilium /00498201/ Review and Motilium /00498201/ Label ), DEXAMETHASONE (2 Mg, Am) (View Dexamethasone Review and Dexamethasone Label ), VISCOLEX (15 Ml, Tid) (View Viscolex Review and Viscolex Label ), ZOLPIDEM TARTRATE (10 Mg, Nocte) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).

6105008-6 | Disease Progression
Patient was taking Oxynorm (View Usage). After Oxynorm was administered, patient had the following side effects: disease progression on Feb 26, 2009 from IRELAND Additional patient health information: Female patient , 78 years of age, was diagnosed with pain (What is pain?) and. Oxynorm dosage: 5 Mg, Unk. During the same period patient was treated with OXYCONTIN (10 Mg, Bid) (View Oxycontin Review and Oxycontin Label ), MOTILIUM /00498201/ (10 Mg, Tid Prn) (View Motilium /00498201/ Review and Motilium /00498201/ Label ), DEXAMETHASONE (2 Mg, Am) (View Dexamethasone Review and Dexamethasone Label ), VISCOLEX (15 Ml, Tid) (View Viscolex Review and Viscolex Label ), ZOLPIDEM TARTRATE (10 Mg, Nocte) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).

5928450-2 | Asthenia, Dysphagia, Dyspnoea, Eyelid Function Disorder, Feeling Abnormal, Hypotonia, Lethargy
Adverse event was reported on Oct 20, 2008 by a Female patient taking Oxynorm (View Usage) (Dosage: 20 Mg, Daily) was diagnosed with pain (What is pain?), epilepsy (What is epilepsy?) and. Location: UNITED KINGDOM , 44 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, dysphagia, dyspnoea, eyelid function disorder, feeling abnormal, hypotonia, lethargy. During the same period patient was treated with PHENYTOIN (300 Mg, Daily) (View Phenytoin Review and Phenytoin Label ).

5916631-3 | Asthenia, Dysphagia, Eyelid Function Disorder, Feeling Abnormal, Hypotonia, Respiratory Disorder
on Oct 06, 2008 Female patient from UNITED KINGDOM , 44 years of age, was diagnosed with sciatica (What is sciatica?) and was treated with Oxynorm (View Usage). Patient had the following side effects: asthenia, dysphagia, eyelid function disorder, feeling abnormal, hypotonia, respiratory disorder. Oxynorm dosage: 1 Df, Qid.

5874070-8 | Hallucination, Hyperkalaemia, Vomiting
on Aug 29, 2008 Male patient from SWEDEN , 88 years of age, was treated with Oxynorm (View Usage). After Oxynorm was administered, patient had the following side effects: hallucination, hyperkalaemia, vomiting. Oxynorm dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LEVOTHYROXINE SODIUM (100 Mcg, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ACETAMINOPHEN (500 Mg, Unk) (View Acetaminophen Review and Acetaminophen Label ), PROPAVAN (25 Mg, Unk) (View Propavan Review and Propavan Label ), BETAPRED (.5 Mg, Unk) (View Betapred Review and Betapred Label ), ETALPHA (.25 Mcg, Unk) (View Etalpha Review and Etalpha Label ), ASPIRIN (75 Mg, Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5116815-0 | Agitation, Coma, Pain
Patient was taking Oxynorm (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, coma, pain (What is pain?) on Aug 22, 2006 from Additional patient health information: Male patient , 61 years of age, was diagnosed with breakthrough pain, agitation and. Oxynorm dosage: 100 Mg, Q12h. During the same period patient was treated with MIDAZOLAM HCL (2 Inj, Twice) (View Midazolam Hcl Review and Midazolam Hcl Label ).

5011004-2 | Accidental Overdose, Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Pressure Decreased, Blood Pressure Increased, Incorrect Dose Administered, Renal Impairment, Sedation
Adverse event was reported on May 08, 2006 by a Male patient taking Oxynorm (View Usage) (Dosage: 20 Ml, Oral) . Location: UNITED KINGDOM , 73 years of age, Patient had the following side effects: accidental overdose, alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood pressure decreased, blood pressure increased, incorrect dose administered, renal impairment, sedation.

5003535-6 | Infusion Related Reaction, Injection Site Erythema, Injection Site Reaction, Injection Site Swelling, Neoplasm Malignant
on Apr 25, 2006 Male patient from SWEDEN , 84 years of age, was diagnosed with arthralgia and was treated with Oxynorm (View Usage). After Oxynorm was administered, patient had the following side effects: infusion related reaction, injection site erythema, injection site reaction, injection site swelling, neoplasm malignant. Oxynorm dosage: See Image,subcutaneous. During the same period patient was treated with PRIMPERAN TAB (4 Ml, Daily, Subcutaneous) (View Primperan Tab Review and Primperan Tab Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), MOVICOL (View Movicol Review and Movicol Label ), FRAGMIN (View Fragmin Review and Fragmin Label ), SODIUM PICOSULFATE (SODIUM PICOSULFATE) (View Sodium Picosulfate (sodium Picosulfate) Review and Sodium Picosulfate (sodium Picosulfate) Label ), BETAPRED (View Betapred Review and Betapred Label ).